オルメサタン誘発性腸病変: FDA有害事象報告システム (FAERS) の症例報告と洞察
Ilaria Mariani1, Giulia Mosini1, Stefania Cheli1
1ICPS, Pharmacovigilance & Clinical Research, Department of Biomedical and Clinical Sciences, University Hospital Luigi Sacco, Università Degli Studi di Milano, Milan, Italy.
Journal of pharmacy practice
|September 6, 2025
まとめ
オルメサタン (ARB) は,スプルーのような腸病と大腸炎に関連しています. この研究は,スプルーのような腸病と,大腸炎との顕著な関連性を確認し,オルメサタンを受けた患者の差分診断に役立ちます.
科学分野:
- 胃腸内科
- 薬用警戒について
- 臨床医学
背景:
- アンジオテンシンII受容体阻害剤 (ARB) であるオルメサタンは高血圧を治療します.
- 記録された有害事象であるスプルーのような腸病と頻繁に関連しています.
- 大腸炎の症例はめったに報告されず,診断に問題がある.
研究 の 目的:
- オルメサタンとスプルーのような腸病と大腸炎の関連性を調べる
- オルメサタンで治療された患者を区別する.
- オルメサタンによる胃腸疾患の臨床的理解と診断を向上させる.
主な方法:
- オルメサタン関連腸病と大腸炎を患った2人の患者の症例報告
- FDAの有害事象報告システム (FAERS) を使用した不均衡性分析.
- アソシエーションの強さを評価するための報告確率比 (ROR) の計算
主要な成果:
- オルメサタンとスプルーのような腸病 (ROR 8499. 53) の間には強い関連性が見られた.
- オルメサタンは大腸炎と有意に関連していた (ROR2. 56).
- 非特異的な症状は,両方の状態の診断を複雑にする.
結論:
- オルメサタンは,スプルーのような腸病と強く関連しており,大腸炎とも関連しています.
- これらの状態を区別することは正確な診断と患者の管理に不可欠です.
- オルメサタンの胃腸の副作用の理解を深めるために,さらなる研究が必要である.
関連する概念動画
Pharmacovigilance
981
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
981
Drug Regulation
1.8K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.8K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
Antihypertensive Drugs: Angiotensin II Receptor Blockers
910
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
910
Drugs for Treatment of Ulcerative Colitis in IBD
236
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
236
Antihypertensive Drugs: Potassium-Sparing Diuretics
746
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
746


